BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Lyka Labs Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
500259
ISIN Demat
INE933A01014
Book Value (Rs)
37.0210703
NSE Symbol
LYKALABS
Divident Yield %
0
Market Cap
(Rs In Cr.)
166
P/E (TTM)
0
EPS (TTM)
0
Face Value
(Rs)
10
Back
Lyka Labs reports consolidated net loss of Rs 3.36 crore in the September 2025 quarter
13-Nov-25   Hrs IST

Net loss of Lyka Labs reported to Rs 3.36 crore in the quarter ended September 2025 as against net profit of Rs 2.10 crore during the previous quarter ended September 2024. Sales declined 10.93% to Rs 36.66 crore in the quarter ended September 2025 as against Rs 41.16 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales36.6641.16 -11
OPM %-6.9312.03 -
PBDT-2.244.44 PL
PBT-4.382.67 PL
NP-3.362.10 PL

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)